Home › Pulmonary Hypertension › North Carolina › Durham
Pulmonary Hypertension clinical trials in Durham, NC
6 studies for Pulmonary Hypertension are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingPhase 3
- USA011, Durham
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- Duke University School of Medicine, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
Xenon MRI Pulm Hypertension
RecruitingPhase 2
- Duke University Medical Center, Durham
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Recruiting
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
129 Xenon Imaging in Patients Treated With Sotatercept
RecruitingPhase 2
- Duke University Medical Center, Durham
Pulmonary Hypertension Association Registry
RecruitingObservational study
- Duke University Medical Center, Durham
- UNC Chapel Hill, Chapel Hill · 10 mi away
About Pulmonary Hypertension
Pulmonary hypertension (PH) is high blood pressure in the arteries to your lungs. It makes your heart work harder, which can lead to heart failure.
More about Pulmonary Hypertension on MedlinePlus
Pulmonary Hypertension trials in other cities
- Philadelphia, PA10 studies
- Aurora, CO9 studies
- Phoenix, AZ9 studies
- Cincinnati, OH8 studies
- Indianapolis, IN8 studies
- New York City, NY8 studies
- Boston, MA8 studies
- Kansas City, KS8 studies
- Charleston, SC7 studies
- Rochester, MN7 studies
- Salt Lake City, UT7 studies
- Houston, TX7 studies
Other studies in Durham
- Breast Cancer64 studies
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Acute Myeloid Leukemia33 studies
- Metastatic Cancer33 studies
- Prostate Cancer32 studies
- Lung Cancer32 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Chronic Lymphocytic Leukemia27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.